Bioregenx (BRGX) Income from Continuing Operations (2022 - 2026)
Bioregenx's (BRGX) quarterly Income from Continuing Operations came in at 126850.0 in Q1 2026, up 52.46% year-on-year from 83199.62 in Q1 2025, and up 87.54% quarter-over-quarter from 1017805.0 in Q4 2025.
Bioregenx (BRGX) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Bioregenx's Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 126850.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 52.46% year-over-year to 126850.0 in Q1 2026; TTM through Mar 2026 was 1403565.0, a 94.23% increase from a year earlier, with the FY2025 full-year figure at 3698991.0, up 85.82% from the prior year.
- Income from Continuing Operations rose to 126850.0 in Q1 2026 per BRGX's latest filing, from 1017805.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2191.0 in Q3 2022 and bottomed at 18204271.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 178345.0 (2025), against an average of 1616425.94.
- Across the five-year window, Income from Continuing Operations sank 79554.84% in 2024 and surged 96.87% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 5535.0 in 2022, then plunged by 12907.52% to 719966.0 in 2023, then plunged by 2428.49% to 18204271.0 in 2024, then soared by 94.41% to 1017805.0 in 2025, then surged by 87.54% to 126850.0 in 2026.
- Per Business Quant, the three latest BRGX Income from Continuing Operations figures stand at 126850.0 (Q1 2026), 1017805.0 (Q4 2025), and 80565.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.68 Bn | 24.36 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 14.66 Bn | 13.76 Bn | 482.22 Mn | 74.28 Mn |
| 3 | Healthequity | 8.28 Bn | 8.02 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.88 Bn | 5.56 Bn | 154.23 Mn | 35.13 Mn |
| 5 | 10x Genomics | 5.81 Bn | 5.27 Bn | 106.18 Mn | -13.47 Mn |
| 6 | MiniMed | 4.51 Bn | 4.21 Bn | 480.00 Mn | -185.00 Mn |
| 7 | Waystar Holding | 4.45 Bn | 4.39 Bn | 216.84 Mn | 43.28 Mn |
| 8 | Doximity | 3.94 Bn | 3.19 Bn | 125.97 Mn | 19.11 Mn |
| 9 | Privia Health | 3.17 Bn | 2.75 Bn | - | 3.71 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | -126,850.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126,850.00 |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -80,565.00 |
| Jun 30, 2025 | -178,345.00 |
| Mar 31, 2025 | -266,854.00 |
| Dec 31, 2024 | -18.20 Mn |
| Sep 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -3.29 Mn |
| Mar 31, 2024 | -704,806.00 |
| Dec 31, 2023 | -719,966.00 |
| Sep 30, 2023 | -3,691.00 |
| Jun 30, 2023 | -4,128.00 |
| Mar 31, 2023 | -229,838.00 |
| Dec 31, 2022 | -5,535.00 |
| Sep 30, 2022 | -2,191.00 |
| Jun 30, 2022 | -33,263.00 |
| Mar 31, 2022 | -37,319.00 |